To confirm the ability of miR-153-3p to repress SNAI1 expression in the HCC cells, hsa-miR-153-3p mimics (GenePharma Co., Shanghai, China) were used to overexpress miR-153-3p in the SNU398 cells, following the manufacturer’s instructions. Here, SNAI1 is linked to hepatocellular carcinoma.